2011501-1000 peopleManufacturer/Trading Company/Service Company
High capacity factory
OEM manufacturer
ODM manufacturer
Product customization
Shipments
204
Key customer
UNIGEN
Key market
🇺🇸 United States
Description
Unigen Vietnam Hanoi Co., Ltd. is a premier manufacturer and subsidiary of the US-based Unigen Corporation, a global leader in the design and production of industrial and enterprise-grade OEM products. Established in Vietnam in 2012 and headquartered in Silicon Valley, the company operates as a comprehensive one-stop solutions provider for Electronic Manufacturing Services (EMS). With a workforce of 500 to 1,000 employees, Unigen Vietnam specializes in high-performance technology solutions including Memory Modules (DRAM, DDR5, SDRAM), Solid State Drives (SSDs), NVDIMMs, and advanced AI solutions such as rugged visual analysis servers and edge server solutions.
Nanogen Pharmaceutical Biotechnology JSC is a pioneering biopharmaceutical manufacturer headquartered in Ho Chi Minh City, Vietnam. Established in 1997, the company has grown into a leading research and innovation-driven enterprise with a workforce of 501 to 1,000 employees. Nanogen operates four advanced manufacturing plants and a dedicated R&D center, maintaining high-quality standards with WHO-GMP and TGA-GMP (Australia) certifications. The company specializes in the development and production of Active Pharmaceutical Ingredients (API), biosimilars, and finished dosage forms, including lyophilized powders, vials, and prefilled syringes.
Their extensive product portfolio focuses on critical therapeutic areas such as Hepatitis B and C treatments, cancer therapeutics, and anemia management. Notable products include PEGNANO, the first biosimilar of its kind in Asia, as well as FACEPTOR and MIRACEL for various oncology applications. Beyond its proprietary product lines, Nanogen provides comprehensive Contract Manufacturing Organization (CMO) and OEM services, leveraging state-of-the-art bioreactor purification systems. The company has a significant international footprint, exporting biological therapies and vaccines to over 15 countries across Asia, Europe, Africa, and the Americas. Nanogen is also recognized for its advanced innovation in vaccine development, notably progressing the NANO COVAX Covid-19 vaccine through Phase 3 clinical trials.